PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $140,000 | -39.4% | 47,941 | -41.4% | 0.00% | -50.0% |
| Q1 2020 | $231,000 | -70.1% | 81,762 | -65.7% | 0.01% | -64.7% |
| Q4 2019 | $773,000 | +28.0% | 238,179 | -14.8% | 0.02% | +21.4% |
| Q3 2019 | $604,000 | -37.9% | 279,557 | -9.7% | 0.01% | -36.4% |
| Q2 2019 | $972,000 | -15.6% | 309,526 | 0.0% | 0.02% | -15.4% |
| Q1 2019 | $1,151,000 | +98.8% | 309,526 | +55.1% | 0.03% | +85.7% |
| Q4 2018 | $579,000 | -20.1% | 199,548 | +128.9% | 0.01% | +16.7% |
| Q1 2014 | $725,000 | -37.9% | 87,194 | -37.0% | 0.01% | -40.0% |
| Q4 2013 | $1,168,000 | -57.5% | 138,364 | -59.9% | 0.02% | -60.0% |
| Q3 2013 | $2,751,000 | -21.8% | 345,221 | -24.2% | 0.05% | -24.2% |
| Q2 2013 | $3,517,000 | – | 455,531 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |